TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 30253206

Group type: EXPERIMENTAL
Intervention: Pavlovian system activity measured with cue-reactivity task
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Goal-directed system activity measured with food-specific delay discounting paradigm
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Cross-paradigm network analysis integrating both tasks
Number of subjects: 30
Study: 29228438

Group type: EXPERIMENTAL
Intervention: Low-dose dezocine (0.05 mg/kg)
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Medium-dose dezocine (0.1 mg/kg)
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: High-dose dezocine (0.15 mg/kg)
Number of subjects: 76

Group type: COMPARATOR
Intervention: Control (fentanyl: 10 μg/kg)
Number of subjects: 76
Study: 25390761

Group type: EXPERIMENTAL
Intervention: Amlodipine 10 mg daily (n = 18, 7 males)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Valsartan 160 mg daily (n = 19, 3 males)
Number of subjects: 37
Study: 23523985

Group type: EXPERIMENTAL
Intervention: Mental imagery-based interventions
Number of subjects: 0
Study: 21851836

Group type: EXPERIMENTAL
Intervention: Smoke-free campus policy
Number of subjects: 3266
Study: 19834427

Group type: EXPERIMENTAL
Intervention: Mangafodipir (5 micromol/kg body weight)
Number of subjects: 7
Study: 18046062

Group type: EXPERIMENTAL
Intervention: Hyperbaric oxygen therapy (HBOT)
Number of subjects: 65
Study: 14977896

Group type: EXPERIMENTAL
Intervention: 2 mg intravaginal prostaglandin E(2) gel
Number of subjects: 36

Group type: COMPARATOR
Intervention: K‐Y jelly (placebo)
Number of subjects: 36
Study: 11697308

Group type: EXPERIMENTAL
Intervention: Vitremer
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Ketac-Bond
Number of subjects: 200

Group type: COMPARATOR
Intervention: Control group (unsealed molars)
Number of subjects: 200
Study: 10205922

Group type: EXPERIMENTAL
Intervention: sulfur salt-bromine-iodine thermal waters
Number of subjects: 50

Group type: COMPARATOR
Intervention: distilled water (placebo)
Number of subjects: 50
Study: 9081851

Group type: EXPERIMENTAL
Intervention: 200 mg micronized form of fenofibrate
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 2081243

Group type: EXPERIMENTAL
Intervention: Large commemorative stamp
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Business-reply stamp
Number of subjects: 0

Group type: COMPARATOR
Intervention: No stamp, metered stamp, small regular stamp
Number of subjects: 0
Study: 6774674

Group type: EXPERIMENTAL
Intervention: Bupivacaine nerve blocks intraoperatively
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Intermittent nerve blocks with bupivacaine
Number of subjects: 31

Group type: COMPARATOR
Intervention: No nerve blocks (Control)
Number of subjects: 31
Study: 31690402

Group type: EXPERIMENTAL
Intervention: Levofloxacin
Number of subjects: 977

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 977

Group type: COMPARATOR
Intervention: Levofloxacin and Placebo
Number of subjects: 977
Study: 29290275

Group type: EXPERIMENTAL
Intervention: Cold gel pad application for 20 minutes in the postpartum first 2 hours and 4 hours after the first application
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Cold gel pad application
Number of subjects: 200
Study: 26317662

Group type: COMPARATOR
Intervention: Placebo (PLA)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Regular Dose of Echinacea-Based Supplement (RD)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Double Dose of Echinacea-Based Supplement (DD)
Number of subjects: 45
Study: 24673056

Group type: EXPERIMENTAL
Intervention: Saturated-dose group (30 cases) - heat-sensitive moxibustion until disappearance of heat-sensitive feeling, treated twice a day for 5 days, then once a day for 30 days.
Number of subjects: 60

Group type: COMPARATOR
Intervention: Traditional-dose group (30 cases) - heat-sensitive moxibustion for 15 minutes each time, treated twice a day for 5 days, then once a day for 30 days.
Number of subjects: 60
Study: 22174391

Group type: EXPERIMENTAL
Intervention: diet + aerobic
Number of subjects: 97

Group type: COMPARATOR
Intervention: diet only
Number of subjects: 97

Group type: COMPARATOR
Intervention: diet + resistance
Number of subjects: 97
Study: 20725056

Group type: EXPERIMENTAL
Intervention: Atenolol monotherapy
Number of subjects: 4703

Group type: EXPERIMENTAL
Intervention: Amlodipine monotherapy
Number of subjects: 4703

Group type: EXPERIMENTAL
Intervention: Atenolol with added diuretic (second-line therapy)
Number of subjects: 4703

Group type: EXPERIMENTAL
Intervention: Amlodipine with added perindopril (second-line therapy)
Number of subjects: 4703
Study: 18303278

Group type: EXPERIMENTAL
Intervention: Preventive measures including fluoride varnish applications, mouthrinsing with 0.12% chlorhexine digluconate, professional oral hygiene.
Number of subjects: 180

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned).
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Test group (preventive measures applied).
Number of subjects: 180
Study: 16269029

Group type: EXPERIMENTAL
Intervention: LongoVital (LV)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Herbs of LongoVital
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 12079956

Group type: EXPERIMENTAL
Intervention: Muscle-sparing thoracotomy technique
Number of subjects: 0
Study: 9212134

Group type: EXPERIMENTAL
Intervention: Bupivacaine + Sufentanil (Group 2)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Bupivacaine (Group 1)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Both Groups
Number of subjects: 100
Study: 8306005

Group type: EXPERIMENTAL
Intervention: Trials with 'significant' results
Number of subjects: 293

Group type: COMPARATOR
Intervention: Trials with 'nonsignificant' results
Number of subjects: 293

Group type: EXPERIMENTAL
Intervention: Combined analysis from this and 3 similar studies
Number of subjects: 293
Study: 3621989

Group type: EXPERIMENTAL
Intervention: 20 mg nifedipine twice daily
Number of subjects: 16

Group type: COMPARATOR
Intervention: 25 mg mefruside once daily
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Combination of nifedipine and mefruside
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Nifedipine and mefruside
Number of subjects: 16
Study: 30572485

Group type: EXPERIMENTAL
Intervention: Preoperative celecoxib analgesia
Number of subjects: 226

Group type: COMPARATOR
Intervention: Postoperative celecoxib analgesia
Number of subjects: 226

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 226
Study: 27217288

Group type: EXPERIMENTAL
Intervention: Very brief intervention for promoting physical activity in primary care (details on dosage and duration not available)
Number of subjects: 16
Study: 25385912

Group type: EXPERIMENTAL
Intervention: Gum-chewing (sugarless gum, 3 times daily for 30 min starting 6 hours postoperatively)
Number of subjects: 180

Group type: COMPARATOR
Intervention: Control (no gum chewing)
Number of subjects: 180
Study: 22079797

Group type: EXPERIMENTAL
Intervention: 100 mg docosahexaenoic acid (G-DHA) daily for 14 days
Number of subjects: 63

Group type: COMPARATOR
Intervention: Olive oil (G-OO) as placebo for 14 days
Number of subjects: 63
Study: 20044087

Group type: EXPERIMENTAL
Intervention: Telmisartan (80 mg)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 18502423

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 15787007

Group type: EXPERIMENTAL
Intervention: Tele-operated robotic ultrasound system
Number of subjects: 0
Study: 11814489

Group type: EXPERIMENTAL
Intervention: Listening to consonant-vowel-consonant (CVC) syllables with restrictions on consonant position
Number of subjects: 0
Study: 10516451

Group type: EXPERIMENTAL
Intervention: Total PSA in liver cirrhosis patients
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Free/total PSA ratio in liver cirrhosis patients
Number of subjects: 75
Study: 10150489

Group type: EXPERIMENTAL
Intervention: Cistinexine dihydrochloride (active drug)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo (control)
Number of subjects: 30
Study: 1988827

Group type: EXPERIMENTAL
Intervention: HA-1A (100 mg intravenous dose in 3.5 g of albumin)
Number of subjects: 543

Group type: COMPARATOR
Intervention: Placebo (3.5 g of albumin)
Number of subjects: 543
Study: 6634894

Group type: EXPERIMENTAL
Intervention: Hydrocortisone (20 mg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (dextrose)
Number of subjects: 0
Study: 31488140

Group type: EXPERIMENTAL
Intervention: Compulsory health-related homework programme
Number of subjects: 675

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 675
Study: 30292597

Group type: EXPERIMENTAL
Intervention: Knotless repair (coreless No. 2 FiberWire interconnected between 3.9‐mm knotless CorkScrew anchors)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Knotted repair (No. 2 FiberWire double pulley with 3.0‐mm SutureTak anchors)
Number of subjects: 14
Study: 27400374

Group type: EXPERIMENTAL
Intervention: Celecoxib 800 mg/day for 14 days before surgery
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Celecoxib treatment
Number of subjects: 45

Group type: COMPARATOR
Intervention: Control group (no NSAID)
Number of subjects: 45
Study: 24766239

Group type: EXPERIMENTAL
Intervention: Supervised endurance and strength training (EST)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 31
Study: 22450001

Group type: EXPERIMENTAL
Intervention: Leaflet distribution
Number of subjects: 2000

Group type: COMPARATOR
Intervention: Non-intervention (control) group
Number of subjects: 2000
Study: 19214090

Group type: EXPERIMENTAL
Intervention: Stochastic resonance (SR) stimulation at various intensity levels (0%, 25%, 50%, 90%)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Stochastic resonance (SR) stimulation
Number of subjects: 18
Study: 17233861

Group type: EXPERIMENTAL
Intervention: Rapid access to ultrasound and CA125 test for women with symptoms; no specific dosage or duration mentioned.
Number of subjects: 317
Study: 15782501

Group type: EXPERIMENTAL
Intervention: Comprehensive interventions including education of former-smokers and improvement of living environment in interventional villages.
Number of subjects: 34436

Group type: EXPERIMENTAL
Intervention: Comprehensive interventions in interventional villages.
Number of subjects: 34436
Study: 12149108

Group type: EXPERIMENTAL
Intervention: Pentoxifylline (400 mg three times a day for 8 weeks)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Pentoxifylline
Number of subjects: 13
Study: 9834911

Group type: EXPERIMENTAL
Intervention: Isoniazid plus rifampin (300 mg isoniazid + 600 mg rifampin per day for 3 months)
Number of subjects: 196

Group type: COMPARATOR
Intervention: Isoniazid (300 mg per day for 9 months)
Number of subjects: 196
Study: 7666798

Group type: EXPERIMENTAL
Intervention: Glutamine 0.28 g/kg BW
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Alpha-ketoglutarate 0.28 g/kg BW
Number of subjects: 33

Group type: COMPARATOR
Intervention: Control (glucose 2 g/kg BW)
Number of subjects: 33
Study: 2760250

Group type: EXPERIMENTAL
Intervention: 0.2% Triclosan/0.5% zinc citrate toothpaste
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 0.5% chlorhexidine/detergent toothpastes
Number of subjects: 0

Group type: COMPARATOR
Intervention: 0.2% chlorhexidine rinse
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Chlorhexidine toothpaste (experimental)
Number of subjects: 0
Study: 692847

Group type: EXPERIMENTAL
Intervention: Right-ear speech targets
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Left-ear musical targets
Number of subjects: 0

Group type: COMPARATOR
Intervention: Dichotic pairs of music or speech
Number of subjects: 0
Study: 30478972

Group type: EXPERIMENTAL
Intervention: Beatalk technique (study group)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Traditional speech therapy (control group)
Number of subjects: 12
Study: 27061732

Group type: EXPERIMENTAL
Intervention: Moderate stress during preparation for a medical exam with high-salt intake
Number of subjects: 10

Group type: COMPARATOR
Intervention: Low stress outside the exam period with high-salt intake
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: High-salt intake during moderate stress
Number of subjects: 10
Study: 25792627

Group type: EXPERIMENTAL
Intervention: Conventional hormone therapy
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Ibandronate monthly
Number of subjects: 60
Study: 23613481

Group type: EXPERIMENTAL
Intervention: Adherence Intervention (AI)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Treatment‐As‐Usual (TAU)
Number of subjects: 30
Study: 20888096

Group type: EXPERIMENTAL
Intervention: High intensity progressive resistance training
Number of subjects: 54

Group type: COMPARATOR
Intervention: Sham-exercise program
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: High intensity progressive resistance training and Sham-exercise program
Number of subjects: 54
Study: 18434881

Group type: EXPERIMENTAL
Intervention: Noninvasive positive pressure ventilation (NIPPV)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Helium/oxygen gas mixtures
Number of subjects: 0
Study: 17058239

Group type: EXPERIMENTAL
Intervention: Hydrocortisone (50 mg/6 h)
Number of subjects: 25

Group type: COMPARATOR
Intervention: No treatment with steroids
Number of subjects: 25
Study: 12629535

Group type: EXPERIMENTAL
Intervention: GTS‐21 (25, 75 and 150 mg)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 10853877

Group type: EXPERIMENTAL
Intervention: Low-dose ATP infusion (25-40 microg kg(‐1) min(‐1))
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Middle-dose ATP infusion (45-60 microg kg(‐1) min(‐1))
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: High-dose ATP infusion (65-75 microg kg(‐1) min(‐1))
Number of subjects: 28
Study: 9165960

Group type: EXPERIMENTAL
Intervention: rocuronium 0.6 mg.kg‐1
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: rocuronium
Number of subjects: 81
Study: 8465356

Group type: EXPERIMENTAL
Intervention: Clinical, laboratory, radiological, and electrocardiographic findings
Number of subjects: 3127

Group type: EXPERIMENTAL
Intervention: Age > 65 years, male sex, dysarthria, multiple attacks, diabetes, angina pectoris, intermittent claudication, CT evidence of cerebral infarct, ECG evidence of anteroseptal infarct, ST depression, left ventricular hypertrophy, left atrial conduction delay
Number of subjects: 3127

Group type: EXPERIMENTAL
Intervention: Monocular attacks only or presence of rotatory dizziness
Number of subjects: 3127
Study: 3839973

Group type: EXPERIMENTAL
Intervention: Sucralfate (6 g per day)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Open sucralfate treatment (after initial placebo)
Number of subjects: 23
Study: 30999870

Group type: EXPERIMENTAL
Intervention: MOVI-da10-Enriched! intervention (n=3 schools)
Number of subjects: 900

Group type: EXPERIMENTAL
Intervention: MOVI-da10-Standard! intervention (n=2 schools)
Number of subjects: 900

Group type: COMPARATOR
Intervention: Control group (n=3 schools)
Number of subjects: 900
Study: 28653394

Group type: EXPERIMENTAL
Intervention: Ranolazine
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 27515331

Group type: EXPERIMENTAL
Intervention: Bioabsorbable cardiac matrix (BCM)
Number of subjects: 303

Group type: COMPARATOR
Intervention: Saline control
Number of subjects: 303
Study: 24316240

Group type: EXPERIMENTAL
Intervention: Fit and Strong! Plus (PA and weight management)
Number of subjects: 400

Group type: COMPARATOR
Intervention: Fit and Strong! (PA only)
Number of subjects: 400
Study: 22543981

Group type: EXPERIMENTAL
Intervention: ADRB1 Arg389 carriers
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: ADRB2 Arg16Gly carriers
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: ADRB2 Arg16/Gln27 carriers
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: eNOS 894GG carriers
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: eNOS 894GT carriers
Number of subjects: 140
Study: 20196185

Group type: EXPERIMENTAL
Intervention: Quetiapine XR (extended release quetiapine fumarate)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Quetiapine IR (immediate release quetiapine)
Number of subjects: 0
Study: 18655973

Group type: EXPERIMENTAL
Intervention: Wavefront parameters alone (WF, n = 11)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Wavefront combined with topography values (WF&VP, n = 10)
Number of subjects: 14
Study: 15197544

Group type: EXPERIMENTAL
Intervention: Calcium supplementation
Number of subjects: 1499

Group type: EXPERIMENTAL
Intervention: Free estradiol index (FEI)
Number of subjects: 1499

Group type: EXPERIMENTAL
Intervention: Hip BMD
Number of subjects: 1499

Group type: EXPERIMENTAL
Intervention: Quantitative ultrasound (QUS) measures
Number of subjects: 1499
Study: 12810993

Group type: EXPERIMENTAL
Intervention: Cyclosporine (3 mg/kg/day, increased to 4 mg/kg after two weeks if response was inadequate)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Methotrexate (0.5 mg/kg weekly)
Number of subjects: 30
Study: 10577636

Group type: EXPERIMENTAL
Intervention: Tirofiban
Number of subjects: 2222
Study: 8913901

Group type: EXPERIMENTAL
Intervention: St. Louis University coding rules for ECG classification
Number of subjects: 4244

Group type: COMPARATOR
Intervention: Standard MC criteria for ECG classification
Number of subjects: 4244
Study: 1862891

Group type: EXPERIMENTAL
Intervention: Intramuscular ketorolac tromethamine (30 mg)
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Intramuscular morphine (10 mg)
Number of subjects: 85

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 85
Study: 6349780

Group type: EXPERIMENTAL
Intervention: Surgery followed by adjuvant chemotherapy (5-FU and methyl-CCNU)
Number of subjects: 312

Group type: COMPARATOR
Intervention: Surgery alone (Control)
Number of subjects: 312
Study: 31911524

Group type: EXPERIMENTAL
Intervention: POPQ-based surgery
Number of subjects: 0

Group type: COMPARATOR
Intervention: Simulated apical support-based surgery
Number of subjects: 0
Study: 31204040

Group type: EXPERIMENTAL
Intervention: Cryotherapy group (intraoral cryotherapy application for 5 minutes after IANB)
Number of subjects: 104

Group type: COMPARATOR
Intervention: Control group (IANB injection with 2% lidocaine)
Number of subjects: 104
Study: 27982750

Group type: EXPERIMENTAL
Intervention: Transcript plus video evidence with a judicial warning
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Video evidence with a judicial warning
Number of subjects: 60

Group type: COMPARATOR
Intervention: Transcript evidence
Number of subjects: 60
Study: 25730446

Group type: EXPERIMENTAL
Intervention: Medical honey gel
Number of subjects: 28

Group type: COMPARATOR
Intervention: Conventional eardrops
Number of subjects: 28
Study: 23522754

Group type: EXPERIMENTAL
Intervention: Sentinel node biopsy (SNB) procedure in multifocal breast cancer patients
Number of subjects: 1026

Group type: COMPARATOR
Intervention: Sentinel node biopsy (SNB) procedure in unifocal breast cancer patients
Number of subjects: 1026

Group type: EXPERIMENTAL
Intervention: Further nodal involvement after a positive sentinel node in multifocal breast cancer patients
Number of subjects: 1026

Group type: COMPARATOR
Intervention: Further nodal involvement after a positive sentinel node in unifocal breast cancer patients
Number of subjects: 1026
Study: 22115144

Group type: EXPERIMENTAL
Intervention: Parental friendship coaching (PFC) - a 3-month parent training intervention targeting peer relationships of children with ADHD
Number of subjects: 62

Group type: COMPARATOR
Intervention: No-treatment control group
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Parental friendship coaching (PFC)
Number of subjects: 62
Study: 19556358

Group type: EXPERIMENTAL
Intervention: Follicular phase (days 6-12)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Luteal phase (days 18-24)
Number of subjects: 9
Study: 17402274

Group type: EXPERIMENTAL
Intervention: Trandolapril 2 mg once daily for 8 weeks
Number of subjects: 120

Group type: COMPARATOR
Intervention: Enalapril 5 mg once daily for 8 weeks
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Trandolapril 2 mg once daily
Number of subjects: 120

Group type: COMPARATOR
Intervention: Enalapril 5 mg once daily
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Trandolapril
Number of subjects: 120

Group type: COMPARATOR
Intervention: Enalapril
Number of subjects: 120
Study: 15613923

Group type: EXPERIMENTAL
Intervention: FoodState Vitamin C complex (500 mg vitamin C, 160 mg bioflavonoids, 600 mg magnesium and 900 mg vitamin B complex)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: FoodState Vitamin C complex
Number of subjects: 25
Study: 11412255

Group type: EXPERIMENTAL
Intervention: Preoperative radiotherapy
Number of subjects: 457

Group type: COMPARATOR
Intervention: Control (non-irradiated patients)
Number of subjects: 457
Study: 9150780

Group type: EXPERIMENTAL
Intervention: Tramadol 1 mg.kg‐1
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Tramadol 0.5 mg.kg‐1
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Tramadol 0.5 mg.kg‐1, 1 mg.kg‐1, and 2 mg.kg‐1
Number of subjects: 104

Group type: COMPARATOR
Intervention: Normal saline (placebo)
Number of subjects: 104
Study: 7715467

Group type: EXPERIMENTAL
Intervention: Estrogen-gestagen replacement therapy
Number of subjects: 2322
Study: 3233896

Group type: EXPERIMENTAL
Intervention: Intravenous push method
Number of subjects: 155

Group type: COMPARATOR
Intervention: Intravenous piggyback method
Number of subjects: 155
Study: 31397124

Group type: EXPERIMENTAL
Intervention: Distal acupoints along meridian plus exercising combined with penetration needling on yang meridians of back
Number of subjects: 60

Group type: COMPARATOR
Intervention: Simple penetration needling on yang meridians of back
Number of subjects: 60
Study: 28454590

Group type: EXPERIMENTAL
Intervention: PEEP of 12 cmH2O with lung recruitment maneuvers (high PEEP)
Number of subjects: 2013

Group type: COMPARATOR
Intervention: PEEP of 4 cmH2O without recruitment maneuvers (low PEEP)
Number of subjects: 2013
Study: 25411207

Group type: EXPERIMENTAL
Intervention: Tai Chi Qigong training (1.5 h/session; 4 sessions/week for 6 months)
Number of subjects: 52

Group type: COMPARATOR
Intervention: No training (control group, n = 27)
Number of subjects: 52
Study: 23669515

Group type: EXPERIMENTAL
Intervention: FITNET (Internet-based cognitive behavioral therapy)
Number of subjects: 112

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: FITNET
Number of subjects: 112